Neil Abdollahian

Neil Abdollahian is an accomplished business executive in the biotech and pharmaceutical industries with extensive experience in business development and corporate strategy. Currently serving as Chief Business Officer at Santa Ana Bio, Inc. since January 2025, Abdollahian’s previous roles include Chief Business Officer at Boundless Bio and Cidara Therapeutics, where Neil led initiatives in oncology and infectious disease therapeutics, respectively. Neil's expertise encompasses transaction advisory work at Clarity Point Partners and a significant tenure at Trius Therapeutics, where strategic partnerships and acquisitions generated substantial non-dilutive funding. Abdollahian holds an MBA in Finance & Technology Management from Pepperdine Graziadio Business School, an M.S. in Biomedical Sciences from The University of New Mexico School of Medicine, and a B.S. in Biological Sciences from The George Washington University.